Palliative listings
June 2, 2016
The Health Department
has updated the Schedule of
Pharmaceutical Benefits, including
changes to the restrictions for a
number of Palliative Care Schedule
items.
Effective this month, the
restrictions have been simplified
and merged under one item code,
with affected items including
bisacodyl, diclofenac, ibuprofen,
indomethacin, methylnaltrexone,
naproxen, paracetamol, rhamnus
frangula and sorbitol+citric acid.
Item codes currently listed for
initial treatment will be retained,
while the item codes for continuing
treatment have been deleted.
The restriction level of some
Palliative Care items will also
change, and under the changes
prescriptions written prior to 01 Jun
2016 for deleted item codes will
remain valid for a twelve month
transition period.
Other changes revealed on the
PBS website yesterday include an
updated list of drugs subject to
price disclosure, 12.5% and 16%
price reductions, ex-manufacturer
pricing and formulary allocations.
New 16% price reductions apply
to acarbose, azacitidine and
eplerenone - see pbs.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 02 Jun 16To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Jun 16
